Nicole LaBrosse, SVP, CFO: Halozyme Therapeutics HALO Planned sale · Filed 05/15

Trade details

Type: Planned sale notice
Stock: Halozyme Therapeutics HALO
Person: Nicole LaBrosseSVP, CFO
Planned sale date: 26/05/15
Filed: 26/05/15

$986.6K to be sold

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 04/15~06/14

Nicole LaBrosse's recent trades

Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$148.9K
1,913 sh
$148.9K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$24.7K
314 sh
$24.7K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1M
13,240 sh
$1M
Filed 25/09/11
Traded 25/09/10
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$509K
6,760 sh
$509K
Filed 25/09/11
Traded 25/09/10
Nicole LaBrosseSVP, CFO
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$1.7M
22,227 sh
$1.7M
Filed 25/09/10
Traded 25/09/10